Paradox Immunotherapeutics

Paradox Immunotherapeutics is an pharmaceutical company developing immunotherapies for rare diseases using a proven-successful immunotherapy drug design platform. The company designs drugs that harness the bodys own immune system to clear lethal deposits from affected organs and reverse organ damage. The company's team has a successful history in d... esigning drug candidates for amyloidosis and taking them from bench to bedside. Using the same platform technology, the company's lead candidate includes a potential treatment for immunoglobulin light chain (AL) cardiac amyloidosis. Their other discovery pipelines include treatments for chronic renal failure and neurodegenerative diseases. With a team of experts in immunotherapy drug design, they possess an orphan drug discovery platform, termed "The PARADOX Platform" for the potential treatment of ~30 rare diseases, a platform technology which has already sparked the interest of major players in the pharmaceutical industry.Read More